Psychometric properties of the Greek Diabetes Treatment Satisfaction Questionnaire

Table 5 Perceived treatment satisfaction, hyper- and hypoglycaemia by demographic and diabetes-related variables

Variable	N (%)	Overall Treatment Satisfaction		Perceived Hyperglycemia		Perceived Hypoglycemia
		Mean	P-value	Mean	P-value	Mean	P-value
Overall	172 (100)	17.48	-	2.58	-	3.53	-
Gender
Male	65 (37.8)	16.86	0.258	2.94	*0.013*	3.91	*0.005*
Female	107 (62.2)	17.85		2.36		3.30
Age group
< 55	33 (19.2)	19.42	0.067	2.67	0.985	3.64	0.908
55-64	38 (22.1)	17.95		2.58		3.47
65-74	59 (34.3)	17.02		2.54		3.58
≥ 75	42 (24.4)	16.17		2.57		3.43
Years with diabetes
1-3	86 (50.0)	18.00	0.273	2.38	0.214	3.42	0.504
4-9	55 (32.0)	17.42		2.78		3.58
≥ 10	31 (18.0)	16.13		2.77		3.74
BMI
18.5-24.9	16 (9.3)	17.69	0.918	2.25	0.232	3.44	0.578
25.0-29.9	70 (40.7)	17.47		2.84		3.66
30.0-34.9	47 (27.3)	17.06		2.34		3.57
≥ 35.0	39 (22.7)	17.48		2.54		3.28
HbA1c
< 6.5% (good)	49 (28.5)	20.43	*< 0.001*	1.53	*< 0.001*	2.41	*< 0.001*
6.5%-7.5% (fair)	74 (43.0)	17.31		2.82		3.86
> 7.5% (poor)	49 (28.5)	14.78		3.27		4.14
Control method
Oral agents	138 (80.2)	18.61	*< 0.001*	2.34	*< 0.001*	3.30	*< 0.001*
Insulin¹	34 (19.8)	12.88		3.56		4.47
≥ 1 comorbidity²
Yes	135 (79.7)	17.16	0.147	2.58	0.951	3.54	0.833
No	37 (20.3)	18.65		2.59		3.49
Coronary/vascular disease
Yes	63 (36.6)	16.07	*0.012*	2.92	*0.021*	3.71	0.180
No	109 (63.4)	18.08		2.39		3.42
≥ 1 microvascular complication³
Yes	13 (7.6)	17.15	0.828	2.62	0.931	3.23	0.417
No	159 (92.4)	17.50		2.58		3.55
Diabetic foot
Yes	11 (6.4)	12.55	*0.002*	3.27	0.108	3.73	0.622
No	161 (93.6)	17.81		2.53		3.52

¹ Approximately half the diabetics in this group take oral agents alongside insulin
² Including hyperlipidaemia, hypertension, arthropathy or COPD
³ Including retinopathy, neuropathy or nephropathy
P-values derived from independent samples t-test or ANOVA

ISSN: 1477-7525